-
Paradigm Therapeutics Recognized Again: SD-101 Nominated for Prestigious Prix Galien USA 2026
A Repeat Achievement in Biotech Innovation Paradigm Therapeutics Inc. has once again solidified its position at the forefront of medical innovation. For the second consecutive year, the company has been nominated for the highly esteemed Prix Galien USA 2026. This recognition highlights the company’s commitment to pushing the boundaries of dermatological science. The Innovation: SD-101…